Drug development timeline: how early characterization prevents regulatory delays
The modern drug development timeline is highly shaped by manufacturing readiness, analytical understanding, and regulatory alignment. While innovation...
Chemistry, Manufacturing, and Controls (CMC) in the drug development process: analytical strategies to support Investigational New Drug (IND) readiness and regulatory progression
The transition from discovery to clinical evaluation represents one of the most critical inflection points in the drug...
Analytical strategies for gene and cell therapy products: From characterization to regulatory expectations
The rapid expansion of advanced therapies has transformed how medicines are designed, manufactured, and evaluated. Unlike traditional pharmaceuticals,...